ATE382048T1 - Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen - Google Patents
Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasenInfo
- Publication number
- ATE382048T1 ATE382048T1 AT03752559T AT03752559T ATE382048T1 AT E382048 T1 ATE382048 T1 AT E382048T1 AT 03752559 T AT03752559 T AT 03752559T AT 03752559 T AT03752559 T AT 03752559T AT E382048 T1 ATE382048 T1 AT E382048T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrazolopyrimdines
- inhibitors
- cyclin dependent
- dependent kinases
- kinases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41213802P | 2002-09-19 | 2002-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE382048T1 true ATE382048T1 (de) | 2008-01-15 |
Family
ID=32030811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03752559T ATE382048T1 (de) | 2002-09-19 | 2003-09-17 | Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen |
Country Status (19)
Country | Link |
---|---|
US (1) | US7151104B2 (de) |
EP (1) | EP1539750B1 (de) |
JP (1) | JP4845380B2 (de) |
KR (1) | KR20050072090A (de) |
CN (1) | CN100475812C (de) |
AR (1) | AR041292A1 (de) |
AT (1) | ATE382048T1 (de) |
AU (1) | AU2003270846B2 (de) |
CA (1) | CA2499593C (de) |
DE (1) | DE60318321T2 (de) |
ES (1) | ES2297203T3 (de) |
HK (1) | HK1071758A1 (de) |
IL (1) | IL167432A (de) |
MX (1) | MXPA05003059A (de) |
MY (1) | MY136840A (de) |
NZ (1) | NZ538595A (de) |
TW (1) | TWI283243B (de) |
WO (1) | WO2004026872A1 (de) |
ZA (1) | ZA200502271B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU756699B2 (en) * | 1996-12-03 | 2003-01-23 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
EP2186811A1 (de) | 2002-08-23 | 2010-05-19 | Sloan-Kettering Institute For Cancer Research | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
WO2006021803A2 (en) * | 2004-08-27 | 2006-03-02 | Cyclacel Limited | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
EP1859797A4 (de) * | 2005-02-28 | 2011-04-13 | Eisai R&D Man Co Ltd | Neue gleichzeitige verwendung einer sulfonamid-verbindung und eines mittels gegen krebs |
WO2006090930A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の新規併用 |
US7304074B2 (en) | 2005-04-05 | 2007-12-04 | Hoffmann-La Roche Inc. | Substituted 1,5-naphthyridine azolinones |
US7417053B2 (en) | 2005-04-07 | 2008-08-26 | Teijin Pharma Limited | Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
TW200716630A (en) * | 2005-04-07 | 2007-05-01 | Teijin Pharma Ltd | Pyrazolo[1,5-a] pyridine derivative or medically acceptable salt thereof |
JP2009507843A (ja) | 2005-09-09 | 2009-02-26 | シェーリング コーポレイション | アザ縮合サイクリン依存性キナーゼ阻害剤 |
CA2670636A1 (en) * | 2006-11-27 | 2008-06-05 | H. Lundbeck A/S | Heteroaryl amide derivatives |
KR20090031122A (ko) * | 2007-09-21 | 2009-03-25 | 주식회사 중외제약 | 인다졸 골격을 함유하는 화합물, 이의 제조방법 및 상기화합물을 함유하는 약제학적 조성물 |
FR2940284B1 (fr) * | 2008-12-19 | 2011-02-18 | Sanofi Aventis | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique |
US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
JP6861166B2 (ja) * | 2015-03-27 | 2021-04-21 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | サイクリン依存性キナーゼの阻害剤 |
US11116755B2 (en) | 2015-11-18 | 2021-09-14 | Genzyme Corporation | Biomarker of polycystic kidney disease and uses thereof |
AU2017323112B2 (en) * | 2016-09-07 | 2020-11-26 | Haihe Biopharma Co., Ltd. | Pyrido five-element aromatic ring compound, preparation method therefor and use thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9611157A (pt) | 1995-11-01 | 1999-03-30 | Novartis Ag | Derivados de purina e processos para sua preparação |
ES2281941T3 (es) | 1997-12-13 | 2007-10-01 | Bristol-Myers Squibb Company | Uso de pirazolo(3,4-b)piridina como inhibidores de quinasa dependiente de ciclina. |
SE9802794D0 (sv) * | 1998-08-21 | 1998-08-21 | Astra Ab | New compounds |
FR2801308B1 (fr) * | 1999-11-19 | 2003-05-09 | Oreal | COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES |
CA2399001C (en) * | 2000-02-03 | 2010-07-20 | Eisai Co., Ltd. | Integrin expression inhibitor |
JP2004516297A (ja) | 2000-12-20 | 2004-06-03 | ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・(エス.セー.エール.アー.エス) | サイクリン依存性キナーゼ(cdk)及びグリコーゲンシンターゼキナーゼ−3(gsk−3)の阻害剤 |
SK10982003A3 (sk) * | 2001-03-08 | 2004-02-03 | Astrazeneca Ab | Nové použitie |
CN1202896C (zh) * | 2002-02-07 | 2005-05-25 | 北京燕化高新技术股份有限公司 | 空气分离时纯化空气的方法 |
-
2003
- 2003-09-17 MY MYPI20033535A patent/MY136840A/en unknown
- 2003-09-17 AT AT03752559T patent/ATE382048T1/de not_active IP Right Cessation
- 2003-09-17 WO PCT/US2003/029841 patent/WO2004026872A1/en active IP Right Grant
- 2003-09-17 CA CA2499593A patent/CA2499593C/en not_active Expired - Fee Related
- 2003-09-17 DE DE60318321T patent/DE60318321T2/de not_active Expired - Lifetime
- 2003-09-17 AR ARP030103374A patent/AR041292A1/es active IP Right Grant
- 2003-09-17 KR KR1020057004435A patent/KR20050072090A/ko active IP Right Grant
- 2003-09-17 US US10/664,337 patent/US7151104B2/en active Active
- 2003-09-17 JP JP2004538405A patent/JP4845380B2/ja not_active Expired - Fee Related
- 2003-09-17 MX MXPA05003059A patent/MXPA05003059A/es active IP Right Grant
- 2003-09-17 ES ES03752559T patent/ES2297203T3/es not_active Expired - Lifetime
- 2003-09-17 NZ NZ538595A patent/NZ538595A/en not_active IP Right Cessation
- 2003-09-17 EP EP03752559A patent/EP1539750B1/de not_active Expired - Lifetime
- 2003-09-17 TW TW092125613A patent/TWI283243B/zh not_active IP Right Cessation
- 2003-09-17 CN CNB038220113A patent/CN100475812C/zh not_active Expired - Fee Related
- 2003-09-17 AU AU2003270846A patent/AU2003270846B2/en not_active Ceased
-
2005
- 2005-03-15 IL IL167432A patent/IL167432A/en not_active IP Right Cessation
- 2005-03-17 ZA ZA200502271A patent/ZA200502271B/en unknown
- 2005-06-15 HK HK05104996A patent/HK1071758A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN100475812C (zh) | 2009-04-08 |
TWI283243B (en) | 2007-07-01 |
HK1071758A1 (en) | 2005-07-29 |
US20040097516A1 (en) | 2004-05-20 |
KR20050072090A (ko) | 2005-07-08 |
ES2297203T3 (es) | 2008-05-01 |
ZA200502271B (en) | 2005-09-19 |
AU2003270846B2 (en) | 2006-11-23 |
US7151104B2 (en) | 2006-12-19 |
CA2499593A1 (en) | 2004-04-01 |
JP4845380B2 (ja) | 2011-12-28 |
NZ538595A (en) | 2006-04-28 |
AU2003270846A1 (en) | 2004-04-08 |
TW200409775A (en) | 2004-06-16 |
EP1539750B1 (de) | 2007-12-26 |
CA2499593C (en) | 2011-08-16 |
IL167432A (en) | 2010-05-17 |
JP2006503060A (ja) | 2006-01-26 |
DE60318321D1 (en) | 2008-02-07 |
AR041292A1 (es) | 2005-05-11 |
CN1681816A (zh) | 2005-10-12 |
WO2004026872A1 (en) | 2004-04-01 |
DE60318321T2 (de) | 2008-12-11 |
MY136840A (en) | 2008-11-28 |
EP1539750A1 (de) | 2005-06-15 |
MXPA05003059A (es) | 2005-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045220L (no) | Heterocykliske inhibitorer for kinaser | |
DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
NO20050636L (no) | Inhibitorer av tyrosinkinaser | |
ATE378336T1 (de) | Imidazopyridine als hemmstoffe cyclin abhängiger kinasen | |
ATE382048T1 (de) | Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen | |
DE60315516D1 (de) | Pyridazinon-derivate als cdk2-hemmer | |
DE60321808D1 (de) | Flavon derivate als inhibitoren von cyclin-abhängigen kinasen | |
DE60313872D1 (de) | Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen | |
ATE378337T1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
PT1562589E (pt) | Diaminotriazoles úteis como inibidores de proteína-quinases | |
ATE455546T1 (de) | Aminotriazol-verbindungen als proteinkinase- hemmer | |
ATE374201T1 (de) | 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase | |
HK1072545A1 (en) | Novel inhibitors of kinases | |
DK1811998T3 (da) | Triazoler anvendelige som inhibitorer af proteinkinaser | |
ATE443706T1 (de) | Pyrrolotriazinverbindungen als kinaseinhibitoren | |
ATE364608T1 (de) | Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen | |
ATE376548T1 (de) | Pyrazolopyrimidine als hemmstoffe cyclin- abhängiger kinasen | |
ATE411306T1 (de) | Biarylsulfonamide als mmp-inhibitoren | |
DE602004026905D1 (de) | 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer | |
ZA200700751B (en) | Azalndoles useful as inhibitors of protein kinases | |
IS7963A (is) | Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa | |
DE60328233D1 (de) | Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren | |
ATE520399T1 (de) | Aminoindazole derivate als kinase inhibitoren | |
ZA200500492B (en) | Novel inhibitors of kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |